ESC 365 - Efficacy and safety of new-generation atrial antitachycardia pacing for atrial tachyarrhythmias in patients implanted with a cardiac resynchronization therapy.

ESC Premium Access

Efficacy and safety of new-generation atrial antitachycardia pacing for atrial tachyarrhythmias in patients implanted with a cardiac resynchronization therapy.

Session: Poster Session 6 - Cardiac resynchronisation therapy : selection and implantation

Topic: Cardiac Resynchronisation Therapy (CRT)

Speaker: Doctor N. Ueda (Osaka, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Nobuhiko Ueda

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)

0 follower

9 more presentations in this session

Normalization of QRS duration to left ventricular dimension improves patient selection for cardiac resynchronization therapy

Speaker: Mr A. Zweerink (Amsterdam, NL)

MPP reduces the ventricular arrhythmias burden compared to standard biventricular pacing in CRT patients

Speaker: Doctor F. Zanon (Rovigo, IT)

Clinical performance of quadripolar left ventricular leads compared to biventricular leads

Speaker: Doctor J. Erath (Frankfurt, DE)

Active fixation lead improves clinical response to cardiac resynchronisation therapy

LV lead apical position could be the best option in selected CRT patients

Speaker: Doctor F. Zanon (Rovigo, IT)

Access the full session

Poster Session 6 - Cardiac resynchronisation therapy : selection and implantation

Speakers: Doctor N. Ueda, Mr A. Zweerink, Doctor F. Zanon, Doctor J. Erath, Doctor F. Zanon

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources